Warning: The NCBI web site requires JavaScript to function. more...
In vitro model for the analysis of synovial fibroblast-mediated degradation of intact cartilage.
Pretzel D, Pohlers D, Weinert S, Kinne RW.
Arthritis Res Ther. 2009;11(1):R25. Epub 2009 Feb 18.
Related citations
The effects of 1 alpha,25-dihydroxyvitamin D(3) on matrix metalloproteinase and prostaglandin E(2) production by cells of the rheumatoid lesion.
Tetlow LC, Woolley DE.
Arthritis Res. 1999;1(1):63-70. Epub 1999 Oct 14.
Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA, Lubberts E, Helsen MM, Saxne T, Coenen-de Roo CJ, Heinegård D, van den Berg WB.
Arthritis Res. 1999;1(1):81-91. Epub 1999 Oct 26.
Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.
Woolley DE, Tetlow LC.
Arthritis Res. 2000;2(1):65-74.
The role of synovial macrophages and macrophage-produced cytokines in driving aggrecanases, matrix metalloproteinases, and other destructive and inflammatory responses in osteoarthritis.
Bondeson J, Wainwright SD, Lauder S, Amos N, Hughes CE.
Arthritis Res Ther. 2006;8(6):R187.
Key regulatory molecules of cartilage destruction in rheumatoid arthritis: an in vitro study.
Andreas K, Lübke C, Häupl T, Dehne T, Morawietz L, Ringe J, Kaps C, Sittinger M.
Arthritis Res Ther. 2008;10(1):R9. Epub 2008 Jan 18.
Suppressive effect of secretory phospholipase A2 inhibitory peptide on interleukin-1beta-induced matrix metalloproteinase production in rheumatoid synovial fibroblasts, and its antiarthritic activity in hTNFtg mice.
Thwin MM, Douni E, Arjunan P, Kollias G, Kumar PV, Gopalakrishnakone P.
Arthritis Res Ther. 2009;11(5):R138. Epub 2009 Sep 18.
TNF-alpha-mediated expression of membrane-type matrix metalloproteinase in rheumatoid synovial fibroblasts.
Migita K, Eguchi K, Kawabe Y, Ichinose Y, Tsukada T, Aoyagi T, Nakamura H, Nagataki S.
Immunology. 1996 Dec;89(4):553-7.
Osteoarthritis and rheumatoid arthritis pannus have similar qualitative metabolic characteristics and pro-inflammatory cytokine response.
Furuzawa-Carballeda J, Macip-Rodríguez PM, Cabral AR.
Clin Exp Rheumatol. 2008 Jul-Aug;26(4):554-60.
Oncostatin M induces angiogenesis and cartilage degradation in rheumatoid arthritis synovial tissue and human cartilage cocultures.
Fearon U, Mullan R, Markham T, Connolly M, Sullivan S, Poole AR, FitzGerald O, Bresnihan B, Veale DJ.
Arthritis Rheum. 2006 Oct;54(10):3152-62.
Human rheumatoid arthritis tissue production of IL-17A drives matrix and cartilage degradation: synergy with tumour necrosis factor-alpha, Oncostatin M and response to biologic therapies.
Moran EM, Mullan R, McCormick J, Connolly M, Sullivan O, Fitzgerald O, Bresnihan B, Veale DJ, Fearon U.
Arthritis Res Ther. 2009;11(4):R113. Epub 2009 Jul 23.
Matrix metalloproteinase 10 promotion of collagenolysis via procollagenase activation: implications for cartilage degradation in arthritis.
Barksby HE, Milner JM, Patterson AM, Peake NJ, Hui W, Robson T, Lakey R, Middleton J, Cawston TE, Richards CD, Rowan AD.
Arthritis Rheum. 2006 Oct;54(10):3244-53.
[Rheumatoid arthritis: new developments in the pathogenesis with special reference to synovial fibroblasts].
Seemayer CA, Distler O, Kuchen S, Müller-Ladner U, Michel BA, Neidhart M, Gay RE, Gay S.
Z Rheumatol. 2001 Oct;60(5):309-18. Review. German.
Macrophage migration inhibitory factor: a mediator of matrix metalloproteinase-2 production in rheumatoid arthritis.
Pakozdi A, Amin MA, Haas CS, Martinez RJ, Haines GK 3rd, Santos LL, Morand EF, David JR, Koch AE.
Arthritis Res Ther. 2006;8(4):R132.
Antirheumatic drug response signatures in human chondrocytes: potential molecular targets to stimulate cartilage regeneration.
Andreas K, Häupl T, Lübke C, Ringe J, Morawietz L, Wachtel A, Sittinger M, Kaps C.
Arthritis Res Ther. 2009;11(1):R15. Epub 2009 Feb 3.
Stimulation of collagenase 3 expression in synovial fibroblasts of patients with rheumatoid arthritis by contact with a three-dimensional collagen matrix or with normal cartilage when coimplanted in NOD/SCID mice.
Wernicke D, Schulze-Westhoff C, Bräuer R, Petrow P, Zacher J, Gay S, Gromnica-Ihle E.
Arthritis Rheum. 2002 Jan;46(1):64-74.
Differential induction and regulation of matrix metalloproteinases in osteoarthritic tissue and fluid synovial fibroblasts.
Fuchs S, Skwara A, Bloch M, Dankbar B.
Osteoarthritis Cartilage. 2004 May;12(5):409-18.
Anti-interleukin-1 and anti-CD44 interventions producing significant inhibition of cartilage destruction in an in vitro model of cartilage invasion by rheumatoid arthritis synovial fibroblasts.
Neidhart M, Gay RE, Gay S.
Arthritis Rheum. 2000 Aug;43(8):1719-28.
A 3D cartilage - inflammatory cell culture system for the modeling of human osteoarthritis.
Sun L, Wang X, Kaplan DL.
Biomaterials. 2011 Aug;32(24):5581-9. Epub 2011 May 12.
Interferon-gamma inhibits interleukin-1beta-induced matrix metalloproteinase production by synovial fibroblasts and protects articular cartilage in early arthritis.
Page CE, Smale S, Carty SM, Amos N, Lauder SN, Goodfellow RM, Richards PJ, Jones SA, Topley N, Williams AS.
Arthritis Res Ther. 2010;12(2):R49. Epub 2010 Mar 22.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on